ASK REDCHAT ANYTHING ABOUT LIPOCINE INC.
Lipocine Inc. (NASDAQ: LPCN)
Listen to this Section
$2.06
+0.0150
(
+0.74% )
68.6K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| LPCN 1107DetailsPreterm birth |
Phase 3 |
| LPCN 1144DetailsNon-alcoholic steatohepatitis |
Phase 3 |
| LPCN 2401DetailsObesity |
Phase 2 |
| LPCN 1148DetailsCirrhosis |
Phase 2 |
| LPCN 2203DetailsEssential tremor |
Phase 1 |
Market Data
|
| Open |
$2.06 |
| Previous Close |
$2.04 |
| Volume |
68.6K |
| Market Cap |
$16.82M |
| Day Range |
$2.00 - $2.16 |
| 52 Week Range |
$1.81 - $12.37 |
| Shares Outstanding |
8.24M |
| Change % |
+0.74% |
| Net Change |
▲ 0.0150 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2012 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-14,704.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-07 |
Sale |
-1764.00 |
Fink Jeffrey Arvin |
| 2024-06-07 |
Sale |
-1764.00 |
Higuchi John W. |
| 2024-06-07 |
Sale |
-1764.00 |
Jene Jill M. |
| 2024-06-07 |
Sale |
-1764.00 |
Ono Richard Dana |
| 2024-06-07 |
Sale |
-1764.00 |
Papapetropoulos Spyros |
| 2024-03-12 |
Sale |
-991.00 |
Fogarty Krista |
| 2024-03-12 |
Sale |
-4893.00 |
Patel Mahesh V. |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
14 |
Nov 06, 2025 |
| 10-q |
Quarterly Reports |
65 |
Nov 06, 2025 |
| 8-k |
8K-related |
15 |
Nov 04, 2025 |
| 8-k |
8K-related |
15 |
Sep 30, 2025 |
| 8-k |
8K-related |
52 |
Sep 26, 2025 |
| 8-k |
8K-related |
39 |
Sep 05, 2025 |
| 8-k |
8K-related |
15 |
Sep 05, 2025 |
| 8-k |
8K-related |
14 |
Aug 26, 2025 |
| 10-q |
Quarterly Reports |
64 |
Aug 05, 2025 |
| 8-k |
8K-related |
14 |
Aug 05, 2025 |